Mandisa Nyati to Anti-HIV Agents
This is a "connection" page, showing publications Mandisa Nyati has written about Anti-HIV Agents.
Connection Strength
0,532
-
Effects of long-term antiretroviral therapy in reproductive-age women in sub-Saharan Africa (the PEPFAR PROMOTE study): a multi-country observational cohort study. Lancet HIV. 2022 Jun; 9(6):e394-e403.
Score: 0,105
-
Machine Learning Algorithms Using Routinely Collected Data Do Not Adequately Predict Viremia to Inform Targeted Services in Postpartum Women Living With HIV. J Acquir Immune Defic Syndr. 2021 12 15; 88(5):439-447.
Score: 0,103
-
Association of Maternal Viral Load and CD4 Count With Perinatal HIV-1 Transmission Risk During Breastfeeding in the PROMISE Postpartum Component. J Acquir Immune Defic Syndr. 2021 10 01; 88(2):206-213.
Score: 0,101
-
Pharmacokinetics and Drug-Drug Interactions of Isoniazid and Efavirenz in Pregnant Women Living With HIV in High TB Incidence Settings: Importance of Genotyping. Clin Pharmacol Ther. 2021 04; 109(4):1034-1044.
Score: 0,095
-
Prevention of HIV-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in HIV-1-Infected Women With High CD4 Cell Count (IMPAACT PROMISE): A Randomized, Open-Label, Clinical Trial. J Acquir Immune Defic Syndr. 2018 04 01; 77(4):383-392.
Score: 0,079
-
Plasma and intracellular tenofovir pharmacokinetics in the neonate (ANRS 12109 trial, step 2). Antimicrob Agents Chemother. 2011 Jun; 55(6):2961-7.
Score: 0,049